Nautilus Biotechnology, Inc.’s Q3 2026 10-Q window runs Oct 26, 2026 to Nov 2, 2026.
Based on 8 prior 10-Q filings.
Nautilus Biotechnology, Inc. · CIK 1808805 · Engraved from SEC EDGAR